Insys Therapeutics Reports First Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- Intel shares fall as competitor reports record results
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Insys Therapeutics (INSY) Declares 2-for-1 Stock Split
May 7, 2015 7:10 AM EDTInsys Therapeutics (INSY) declared a 2-for-1 stock split.
The stock split is payable on June 5, 2015 to stockholders of record on May 26, 2015, with an ex-date of June 8, 2015.
Total shares outstanding will increase from approximately 35.7 million to 71.4 million shares.
For stock split history and other stock split-related data on... More
Insys Therapeutics (INSY) Tops Q1 EPS by 23c
May 7, 2015 6:51 AM EDTInsys Therapeutics (NASDAQ: INSY) reported Q1 EPS of $0.63, $0.23 better than the analyst estimate of $0.40. Revenue for the quarter came in at $70.8 million versus the consensus estimate of $70.9 million.
Net income of $8.0 million, or $0.23 per basic and $0.21 per diluted share, compared to net income... More



